Recent Articles

• 
  Medical / Drug Development

  Targeted NSCLC Therapy Boosts Market Competitiveness

  JintzBio Co., Ltd. won the top award in the Anticancer New Drug category at the “2026 National Industrial Awards.” Established in 2020, JintzBio is a biotechnology company specializing in anticancer agents and treatments for rare diseases, and is leading innovation in the field of non-small cell lun

  2026.04.16
• 
  Celltrion / Biopharma

  U.S. Drug Policy Boosts Celltrion Biosimilars

  Panoramic view of the Celltrion Branchburg plant signage. Provided by Celltrion The United States, the world’s largest pharmaceutical market, is rolling out a series of policies that are set to change the local healthcare environment. These policies are designed to curb U.S. government healthcare sp

  2026.04.15
• 
  Startup (Healthcare)

  Foot Specialist Startup Dr. Podi Disrupts Insole Market

  CEO Park Eun-soo Pureun Cheongnyeon Co., Ltd. has won the Grand Prize in the Healthcare category at the “2026 Korea Industry Awards.”The core of this award is that a foot specialist directly founded the company and developed functional insoles based on clinical data, successfully targeting the gap b

  2026.04.15
• 
  K-Beauty

  PDRN-Hyaluronic Microtechnology Drives Skin Regeneration

  CEO Jin Hye-young MiWineMore has won the Grand Prize in the beauty category at the “2026 Korea Industry Awards.”The key factor in the company’s award is that it pioneered a new market for “procedure-free skin regeneration” by transplanting original technology from the medical dressing field into cos

  2026.04.15
• 
  Global Supply Chain

  Kolmar, Woori Bank Launch KRW 174 Billion Finance Network

  KOLMAR Korea researcher. Courtesy of KOLMAR Korea KOLMAR Korea is taking the lead in securing the global competitiveness of K-beauty by becoming the first company in the cosmetics manufacturing industry to contribute capital to a government export financing support program. Through collaboration wit

  2026.04.14
• 
  Medical / Research

  Closing Cancer Diagnosis Gap: Kim Han-gyeom Honored

  Kim Han-gyeom, head of the International Diagnostic Center at Hanaro Medical Foundation, poses for a commemorative photograph after receiving a Merit Award at the Korean Society for Cytopathology conference. Provided by Hanaro Medical Foundation The International Diagnostic Center Director of Hanaro

  2026.04.14
• 
  Medical / Drug Development

  Smart Patch Uses Light to Control Drug Doses

  Schematic of a photo-pharmaceutical combination therapy using an OLED patch. (Provided by KAIST. Resale and DB prohibited) 2026.4.13/News1 A “smart patch” that accelerates wound healing more than ointments or adhesive bandages has been developed. KAIST announced on the 13th that a research team led

  2026.04.13
• 
  AI Healthcare

  ARPI Only Korean Firm at Mayo Clinic Showcase

  Photo courtesy of ARPI Medical AI company ARPI (CEO Kim Joong-hee) announced that it participated in the “Mayo Clinic Platform_Accelerate Showcase,” held in Rochester, Minnesota, United States, from the 7th to the 8th. ARPI was the only Korean company among the 25 global healthcare companies partici

  2026.04.09
• 
  Medical / Research

  Cervical Cancer Test Uses Vaginal Discharge

  Oh Young-taek, Professor of Obstetrics and Gynecology at Korea University Ansan Hospital. Courtesy of Korea University Ansan Hospital Professor Oh Young-taek of the Department of Obstetrics and Gynecology at Korea University Ansan Hospital has presented a non-invasive precision diagnostic technology

  2026.04.08
• 
  AI Healthcare

  Health capsule: Model predicts delayed relapse in young breast cancer

  ■ Development of a Predictive Model for Delayed Recurrence in Young Breast Cancer Patients, etc. A model has been developed that can predict the risk of recurrence after 5 years in young breast cancer patients. Estrogen receptor-positive (ER+) and human epidermal growth factor receptor 2-negative (H

  2026.04.08